UNITEDHEALTH GROUP INC
A diversified healthcare leader combining insurance coverage with advanced technology services through Optum.
A diversified healthcare leader combining insurance coverage with advanced technology services through Optum.
UnitedHealth benefits from secular tailwinds including an aging population and expanding Medicare Advantage enrollment, which supports long-term revenue growth. The Optum segment continues to generate high-margin non-insurance revenue that diversifies earnings beyond traditional healthcare payers.
Significant year-over-year decline in net income raises concerns about the sustainability of current profitability amidst increasing operating expenses. Heavy debt levels with $72.36B in long-term debt and large accumulated other comprehensive losses create financial leverage risks during economic downturns or rising interest rate environments.
UnitedHealth Group is a global health care service and benefits company providing coverage through UnitedHealthcare and delivering services via Optum. Operating primarily in the United States, it serves individuals and employers with medical, dental, and vision plans alongside pharmacy benefit management and data analytics solutions. The company leverages its integrated ecosystem to deliver comprehensive care across hospitals, physician practices, and home health settings.
While revenue grew to $400.28B in 2024, net income dropped significantly to $15.24B compared to $23.14B the prior year, indicating potential margin compression or one-time charges. The company maintained strong cash flow from operations at $24.20B but saw a notable decline in cash reserves with ending cash of $25.31B despite substantial share repurchases of $9.00B.
The US healthcare industry is facing structural changes driven by an aging demographic, technological innovation, and ongoing regulatory reforms aimed at controlling costs. UnitedHealth Group is well-positioned within this sector due to its diversified business model that spans insurance administration, provider services, and technology solutions.
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $324.16B | $371.62B | $400.28B |
| Cost of Revenue | $33.70B | $38.77B | $46.69B |
| Gross Profit | $290.46B | $332.85B | $353.58B |
| Operating Expenses | $262.02B | $300.49B | $321.30B |
| Operating Income | $28.43B | $32.36B | $32.29B |
| G&A | $47.78B | $54.63B | $53.01B |
| Stock-Based Comp | $925.0M | $1.06B | $1.02B |
| D&A | $3.40B | $3.97B | $4.10B |
| Depreciation | $1.10B | $1.10B | $1.00B |
| Amortization | $1.30B | $1.60B | $1.70B |
| Other OpEx | $214.24B | $245.87B | $268.28B |
| Non-Operating Income | $-2.09B | $-3.25B | $-12.22B |
| Interest Expense | $2.09B | $3.25B | $3.91B |
| Pre-Tax Income | $26.34B | $29.11B | $20.07B |
| Income Tax | $5.70B | $5.97B | $4.83B |
| Continuing Ops | $20.64B | $23.14B | $15.24B |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $20.64B | $23.14B | $15.24B |
| Minority Interest | $519.0M | $763.0M | $837.0M |
| Net to Common | $20.12B | $22.38B | $14.40B |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $69.07B | $78.44B | $85.78B |
| Cash & Equivalents | $23.36B | $25.43B | $25.31B |
| Marketable Securities | $4.55B | $4.20B | $3.80B |
| Accounts Receivable | $17.68B | $21.28B | $22.36B |
| Inventory | $3.50B | $2.80B | $3.80B |
| Prepaid Expenses | $6.62B | $6.08B | $8.21B |
| Other Current Assets | $13.36B | $18.65B | $22.29B |
| Long-Term Assets | $176.64B | $195.28B | $212.50B |
| PP&E (Net) | $10.13B | $11.45B | $10.55B |
| Intangibles | $14.40B | $15.19B | $23.27B |
| Goodwill | $93.35B | $103.73B | $106.73B |
| LT Investments | $43.73B | $47.61B | $52.35B |
| Other LT Assets | $13.53B | $15.90B | $15.79B |
| Total Assets | $245.71B | $273.72B | $298.28B |
| Current Liabilities | $89.24B | $99.05B | $103.77B |
| Long-Term Liabilities | $70.12B | $75.75B | $91.92B |
| Long-Term Debt | $54.51B | $58.26B | $72.36B |
| Other LT Liab | $15.61B | $17.48B | $19.56B |
| Total Liabilities | $159.36B | $174.80B | $195.69B |
| Shareholders' Equity | $86.35B | $98.92B | $102.59B |
| Retained Earnings | $86.16B | $95.77B | $96.04B |
| AOCI | $-8.39B | $-7.03B | $-3.39B |
| Total L&E | $245.71B | $273.72B | $298.28B |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $20.64B | $23.14B | $15.24B |
| Non-Cash Adjustments | $-10.02B | $-6.31B | $176.0M |
| Working Capital Changes | $15.59B | $12.24B | $8.79B |
| Cash from Operations | $26.21B | $29.07B | $24.20B |
| Capital Expenditures | $2.80B | $3.39B | $3.50B |
| Cash from Investing | $-28.48B | $-15.57B | $-20.53B |
| Debt Issuances | $14.82B | $6.39B | $17.81B |
| Debt Repayments | $3.02B | $2.12B | $3.00B |
| Share Buybacks | $7.00B | $8.00B | $9.00B |
| Dividends Paid | $5.99B | $6.76B | $7.53B |
| Cash from Financing | $4.23B | $-11.53B | $-3.51B |
| FX Effect | $34.0M | $97.0M | $-61.0M |
| Net Change in Cash | $1.99B | $2.06B | $-115.0M |
| Beginning Cash | $21.38B | $23.36B | $25.43B |
| Ending Cash | $23.36B | $25.43B | $25.31B |
UnitedHealthcare delivers medical and dental benefits including Medicare Advantage and Medicaid plans, while Optum provides pharmacy benefits management, data analytics, and clinical services. The company also offers consumer-focused products such as Change Healthcare and HomeCare Plus to support care delivery and wellness initiatives.
Regulatory pressure on Medicare Advantage reimbursement rates and potential new legislation affecting the Affordable Care Act, cybersecurity threats targeting sensitive member health data, and exposure to rising medical cost trends that could impact operating margins.
Proprietary data network derived from member interactions enabling superior risk prediction and care coordination, massive scale in Medicare Advantage plans driving pricing power, and a vertically integrated Optum model capturing value across insurance, pharmacy, and technology.
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.